April 2024 - Page 5 of 18

TuesdayApr 23, 2024 9:00 am

SuperCom Ltd. (NASDAQ: SPCB) Electronic Monitoring Technology Addresses Important Concerns in Dealing with Youthful Offenders

Developments in Australia’s efforts to limit youth offender recidivism underscore the importance of being able to track select probationary participants Israel-based SuperCom Ltd. is positioning itself to be a world leader in providing court-administered offender tracking, which may include youths potentially prone to recidivism The company is growing on a global scale with contracts in Romania, Finland, Croatia, Sweden, and various states in the United States, in a marketplace with an anticipated 9.5 percent CAGR over the next five years An Australian court’s decision to have young criminal suspects wear electronic ankle bracelet monitors is helping law enforcement advocates successfully…

MondayApr 22, 2024 3:45 pm

QualityStocksNewsBreaks – NRx Pharmaceuticals Inc. Releases Pricing of Public Offering, Expected to Result in Estimated $2M

NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, has announced the pricing of its underwritten public offering. The offering is comprised of shares of NRXP common stock at $3.30 per share, resulting in gross proceeds of an estimated $2 million before standard underwriting deductions and other expenses. According to the announcement, NRx Pharmaceuticals also granted a 45-day option to underwriters. The option allows the purchase of up to 91,050 additional shares of common stock to cover overallotments; the shares will be available at the public offering price less the underwriting discounts. NRx Pharmaceuticals anticipates using funds from the offering for working capital,…

MondayApr 22, 2024 3:31 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Spotlighted in Upcoming Virtual Investor Lunch Break Event

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, will be featured on the Virtual Investor Lunch Break: The CNSP Opportunity event. During the live video webcast, which is scheduled to begin at 12 p.m. EST, CEO John Climaco will present a corporate overview. He will also discuss the company’s business outlook and opportunity. In addition, the event provides an opportunity for those participating to submit questions; Climaco will answer as many questions as possible I the time provided. A replay of the presentation will…

MondayApr 22, 2024 2:24 pm

QualityStocksNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Marks Phase One Completion of Battery Line Integration

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced the first phase completion of battery line integration at its high energy facility located in Fullerton, California. According to the announcement, the southern California facility is dedicated to producing next-generation American-made EV battery packs, a critical component to Mullen’s commitment to zero emissions and to reducing reliance on key battery components imported from foreign countries. “Our new battery assembly plant is not just an investment in Mullen Automotive's future, but also a testament to our commitment towards U.S. battery production,” said David Michery, CEO of Mullen Automotive. “Battery…

MondayApr 22, 2024 12:53 pm

QualityStocksNewsBreaks – EF Hutton to Host Annual Global Conference in NYC, Spotlighting Strategic Growth and Investor Connections

EF Hutton, a full-service investment bank headquartered in New York, NY, recently announced additional details regarding its Annual Global Conference being hosted at the Plaza Hotel in New York City on May 15, 2024. The event will provide a platform for corporate executives, institutional investors, and family offices to network, exchange ideas, and explore potential collaborations in both individual and group settings. Following the triumph of last year’s gathering, the investment bank is attracting a premier roster of growth-oriented companies, as well as its corporate clients, institutional investors, high-net-worth individuals, and a select group of business media representatives. "At its…

MondayApr 22, 2024 12:20 pm

QualityStocksNewsBreaks – Upstream Featured in Recent Article Discussing Increasing Shareholder Engagement

Upstream, the revolutionary retail trading app for stocks and NFTs powered by Horizon Fintex and MERJ Exchange Limited, offers a unique platform designed to empower issuers to not only reach a global investor base but also build deeper connections with both new and existing shareholders. The company was spotlighted in an article discussing how to leverage digital communication; the article also stated that shareholder engagement is more important than ever. Methods of communicating with shareholders include the traditional email, meetings and press releases; however, forward-thinking issuers are looking to modern digital communications to engage more meaningfully with investors. These methods can include…

MondayApr 22, 2024 12:00 pm

Energy and Water Development Corp. (EAWD) Is ‘One to Watch’

EAWD is a green-tech engineering solutions company that builds water and energy systems for clients, including private companies, government entities and NGOs The company has sold and deployed its water systems in Mexico and Germany Using its patent-pending design, EAWD is working to build and operate off-grid EV charging stations in Germany In December 2023, the company announced a joint Memorandum of Understanding to build the first off-grid atmosphere water generation plant in North America Energy and Water Development (OTCQB: EAWD) is a green-tech engineering solutions company focused on delivering water and energy to extreme environments. The company builds water…

MondayApr 22, 2024 11:15 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Marks GLP-1 Study Milestone with Ethics Review Board Approval

Lexaria, a global innovator in drug delivery platforms, has received approval for its GLP-1 human pilot study #2 by an independent third-party ethics review board GLP-1 drugs are utilized in the treatment of type 2 diabetes and obesity, a huge market, and are typically administered by painful and expensive injection, offering a major opportunity for Lexaria’s oral delivery platform This approval sets the company up for dosing within 30 days or less, with tentative study completion dates for this summer The study will comprise two study arms, the second study arm will investigate whether Lexaria’s patented DehydraTECH(TM)-enhanced semaglutide can effectively…

MondayApr 22, 2024 11:11 am

QualityStocksNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA:0K9A) Issues Update on Celly Nu’s Pending Launch of unbuzzd(TM)

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA:0K9A) today provided an update by way of a news release issued by Celly Nutrition Corp. (“Celly Nu”), and its launching of unbuzzd(TM), an innovative beverage product that is scientifically formulated from a proprietary blend of vitamins, minerals and botanical extracts designed to support the body’s natural processes for metabolizing alcohol and promoting alertness. According to the announcement, on April 22, 2024, Celly Nu announced a strategic partnership with BevSource, a St. Paul, Minnesota-based leading provider of beverage development, production and operations solutions. The partnership will assist with the production and distribution process of…

MondayApr 22, 2024 10:30 am

Clene Inc. (NASDAQ: CLNN) Continues Development of Lead Drug Candidate CNM Au8(R) for Neurodegenerative Diseases including Parkinson’s Disease

CNM-Au8 is an oral suspension with demonstrated activity in restoring neuronal health and function by increasing energy production and utilization Treatment with CNM-Au8 investigated in clinical trials adjunctive to standard-of-care exhibits no known drug interactions, and aims to enhance function and survival Nearly 90,000 people are diagnosed with Parkinson's disease every year with no approved drug to slow or halt disease progression currently available The Parkinson's disease treatment market was valued at $4.61 billion in 2022 and is expected to reach $11.98 billion by 2030 In recognition of April as Parkinson’s Disease Awareness Month, IBN is highlighting Clene (NASDAQ: CLNN),…

Site Search

Company Search

Month: April 2024